Endocrinology Network is now HCPLive Endocrinology! HCPLive Endocrinology is your resource for breaking news and expert-driven insights in endocrinology and diabetes care.
External link for HCPLive Endocrinology
2 Clarke Drive
Cranbury, New Jersey 08512, US
HCPLive Endocrinology reposted this
Article of the Week: An analysis from Cedars-Sinai using records from 40 million US patients in the TriNetX database highlights the surge in new GLP-1 receptor agonist use, with semaglutide dominating new prescriptions since 2020.
HCPLive Endocrinology reposted this
New data and advances have transformed conversations around management of #ChronicKidneyDisease, begging the question: Is it time to discuss combination therapy approaches? Hear from Brendon L Neuen, MBBS, PhD, of The George Institute for Global Health, on recent data from the SMART-C consortium and what is next for #nephrology: https://lnkd.in/e58DuXBe
Subscribe to our monthly newsletter for a regular roundup of the latest approvals and regulatory decisions from the US FDA on the first Saturday of each month!
Get a rundown of the FDA's 20 novel drug approvals from the first half of 2024 in the first edition of the Provider's Digest, a monthly LinkedIn newsletter spotlighting regulatory decisions and approvals from the US Food and Drug Administration. Subscribe to get a monthly recap of FDA news from the prior month every first Saturday of each month! #FDANews #Healthcare #Medicine
HCPLive Endocrinology reposted this
To celebrate the conclusion of the 84th American Diabetes Association Scientific Sessions, we're posting the full episode of #DiabetesDialogue with Robert Gabbay MD, PhD here on LinkedIn! Hear from Dr. Gabbay as he discusses the launch of the Obesity Association with Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES and Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES: https://lnkd.in/ezMR8Kw5 #Obesity #ADASciSessions
Let us know what you want to hear about from our post-ADA recap episode in the comments section! #Diabetes #ADA24 #ADA2024
Diabetes Dialogue wants to hear from you! We're planning a special "mailbag" episode for our post-ADA conference recap episode. Let us know your biggest, most pressing questions from the American Diabetes Association 84th Scientific Sessions in the comment below and our hosts, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES and Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES, will answer them in our post-conference recap! Follow all our coverage of #ADA2024 using the link below: https://lnkd.in/ehpJJqS #Diabetes
Follow along for the latest in endocrinology and diabetes management from #ADA24!
We are one week away from the American Diabetes Association annual meeting in Orlando, Florida! Follow us for the latest updates in diabetes management and endocrinology directly from the conference floor, including on-site interviews and episodes of #DiabetesDialogue, HCPLive Endocrinology's flagship podcast, hosted by Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES and Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES! #ADA2024
HCPLive Endocrinology reposted this
The FLOW trial officially ushers in a new age in the management of chronic kidney disease in type 2 diabetes, introducing semaglutide and GLP-1 receptor agonists as a pillar of therapy among these patients. Check out our interview from #ERA24 with principal investigator Vlado Perkovic, MBBS, PhD, of UNSW and The George Institute for Global Health, on the results and their implications on care: https://lnkd.in/eSHAPm6E
HCPLive Endocrinology reposted this
Need a breakdown of what the FLOW trial means from the frontlines of diabetes management? Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES and Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES have you covered with their newest episode of #DiabetesDialogue where they break down what FLOW means for the role of semaglutide in managing #Type2Diabetes and chronic kidney disease. https://lnkd.in/eaEShUz4 #ERA24 #ChronicKidneyDisease
HCPLive Endocrinology reposted this
Can't get enough of the FLOW trial from #ERA24? We've got you covered! Check out our article, lead investigator interview, and the latest episode of #DiabetesDialogue. 📰: https://lnkd.in/eqwSrE_6 🎥: https://lnkd.in/eSHAPm6E 🎙️: https://lnkd.in/eaEShUz4
Check out our coverage of the FLOW trial and what it means for use of semaglutide (Ozempic; Novo Nordisk) in patients with T2D and chronic kidney disease!
Couldn't make it to #ERA2024 or snag a seat at the presentation? We've got you covered with our coverage of the FLOW trial! Check back later this weekend for our interviews with investigators from this landmark, practice-shifting trial: https://lnkd.in/eqwSrE_6 #Diabetes #ChronicKidneyDisease